Cyclin B1 overexpression in conventional oral squamous cell carcinoma and verrucous carcinoma-A correlation with clinicopathological features

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 18, Issue 4, 2013, Pages

  Patil, Gururaj B ^a   Hallikeri, Kaveri S ^b   Balappanavar, Aswini Y ^a   Hongal, Sudheer G ^c   Sanjaya, P R ^d   Sagari, Sheetalkumar G ^a  

^a Jodhpur National University   (India)

^b SDM COLLEGE OF DENTAL SCIENCES AND HOSPITAL   (India)

^c People s Dental Academy   (India)

^d Government Dental College and Hospital   (India)

Author keywords

Cyclin B1; Head and neck cancer; Oral squamous cell carcinoma; Verrucous carcinoma

Indexed keywords

CYCLIN B1;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; VERRUCOUS CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CARCINOMA, VERRUCOUS; CROSS-SECTIONAL STUDIES; CYCLIN B1; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84880431834     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.18220     Document Type: Article

References (24)

1. Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med. 2002;13:51-61.
2. Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med. 1999;28:226-32.
3. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 2002;8:817-22.
4. Li JM, Brooks G. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?. Eur Heart J. 1999;20:406-20.
5. van Leuken R, Clijsters L, Wolthuis R. To cell cycle, swing the APC/C. Biochim Biophys Acta. 2008;1786:49-59.
6. Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67-76.
7. Kushner J, Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med. 1999;28:77-81.
8. Pereira MC, Oliveira DT, Landman G, Kowalski LP. Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc. 2007;73:339-44.
9. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W, et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:2874-81.
10. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, et al. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis. 2008;29:307-15.
11. Hoffmann TK, Trellakis S, Okulicz K, Schuler P, Greve J, Arnolds J, et al. Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer Res. 2011;31:3151-7.
12. Geddert H, Heep HJ, Gabbert HE, Sarbia M. Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus. Cancer. 2002;94:212-8.
13. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, et al. Integrative analysis of cyclin protein levels iden tifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res. 2009;15:3654-62.
14. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res. 2001;7:2458-62.
15. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res. 2002;62:6414-7.
16. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol. 2004;15:252-6.
17. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 2000;60:4000-4.
18. Grabsch H, Lickvers K, Hansen O, Takeno S, Willers R, Stock W, et al. Prognostic value of cyclin B1 protein expression in colorectal cancer. Am J Clin Pathol. 2004;122:511-6.
19. Lao-Sirieix P, Brais R, Lovat L, Coleman N, Fitzgerald RC. Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis. Neoplasia. 2004;6:751-60.
20. Lawoyin JO, Lawoyin DO, Aderinokun G. Intra-oral squamous cell carcinoma in Ibadan: a review of 90 cases. Afr J Med Med Sci. 1997;26:187-8.
21. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128:268-74.
22. de Spíndula-Filho JV, da Cruz AD, Oton-Leite AF, Batista AC, Leles CR, de Cássia Gonçalves Alencar R, et al. Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV). Tumour Biol. 2011;32:409-16.
23. Watanabe S, Watanabe R, Oton-Leite AF, Alencar Rde C, Oliveira JC, Leles CR, et al. Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma. J Oral Sci. 2010;52:417-24.
24. Yoshitome S, Furuno N, Hashimoto E, Sagata N. The C-terminal seven amino acids in the cytoplasmic retention signal region of cyclin B2 are required for normal bipolar spindle formation in Xenopus oocytes and embryos. Mol Cancer Res. 2003;1:589-97.